| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adagio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75,000 | 22 Jun 2022 | Direct | ||
| PepGen Inc. | Director | Stock Option (Right to Buy) | 16,000 | 04 Jun 2025 | Direct | ||
| Entasis Therapeutics Holdings Inc. | Director | Common Stock | 0 | $2.20 | 11 Jul 2022 | Direct | |
| Entasis Therapeutics Holdings Inc. | Director | Stock Option (right to buy) | 0 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PEPG | PepGen Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 06:56 |
| PEPG | PepGen Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:04 |
| PEPG | PepGen Inc. | 10 Nov 2023 | 1 | $0 | 4 | Director | 14 Nov 2023, 19:11 |
| PEPG | PepGen Inc. | 10 Nov 2023 | 0 | $0 | 3 | Director | 14 Nov 2023, 19:04 |
| ETTX | Entasis Therapeutics Holdings Inc. | 07 Jul 2022 | 4 | -$108,900 | 4 | Director | 11 Jul 2022, 16:06 |
| IVVD | Adagio Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:36 |
| ETTX | Entasis Therapeutics Holdings Inc. | 18 Jan 2022 | 1 | $0 | 4 | Director | 19 Jan 2022, 15:03 |
| IVVD | Adagio Therapeutics, Inc. | 05 Aug 2021 | 1 | $0 | 4 | Director | 09 Aug 2021, 19:59 |
| IVVD | Adagio Therapeutics, Inc. | 05 Aug 2021 | 0 | $0 | 3 | Director | 05 Aug 2021, 21:23 |
| ETTX | Entasis Therapeutics Holdings Inc. | 16 Jul 2021 | 2 | $0 | 4 | Director | 15 Feb 2022, 15:03 |